Neuroendocrine and neuropeptide dysregulation in anorexia nervosa, bulimia nervosa, and binge eating disorder

Clinical Handbook of Eating Disorders: An Integrated Approach

Volumn , Issue , 2004, Pages 283-296

  Bailer, Ursula F ^a   Kaye, Walter H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84973664896     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (78)

1. Pirke KM, Pahl J, Schweiger U. Metabolic and endocrine indices of starvation in bulimia: a comparison with anorexia nervosa. Psychiatry Res 1985; 15:33-39.
2. Tomova A, Kumanov P, Kirilov G. Factors related to sex hormone binding globulin concentrations in women with anorexia nervosa. Psychosom Med 1995; 40:499-506.
3. Gold PW, Gwirtsman H, Avgerinos PC, Nieman LK, Gallucci WT, Kaye W, Jimerson D, Ebert M, Rittmaster R, Loriaux DL. Abnormal hypothalamicpituitaryadrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients. N Engl J Med 1986; 314:1335-1342.
4. Fichter MM, Pirke KM, Pollinger J, et al. Disturbances in the hypothalamopituitary-adrenal and other neuroendocrine axes in bulimia. Biol Psychiatry 1990; 27:1021-1037.
5. Yanovski SZ, Yanovski JA, Gwirtsman HE, Bernat A, Gold PG, Chrousos GP. Normal dexamethasone suppression in obese binge and nonbinge eaters with rapid weight loss. J Clin Endocrinol Metab 1993; 76:675-679.
6. Yanovski SZ. Biological correlates of binge eating. Addict Behav 1995; 20:705-712.
7. Adami GF, Gandolfo P, Campostano A, Cocchi F, Bauer B, Scopinaro N. Obese binge eaters: metabolic characteristics, energy expenditure, and dieting. Psychol Med 1995; 25:195-198.
8. Wartofsky L, Burman KD. Alterations in throid function in patients with systemic illness: the “euthyroid sick syndrome.” Endocr Rev 1982; 3:164-217.
9. Altemus M, Hetherington M, Kennedy B, et al. Thyroid function in bulimia nervosa. Psychoneuroendocrinology 1996; 21:249-261.
10. Lesem MD, Kaye WH, Bissette G, et al. Cerebrospinal fluid TRH immunoreactivity in anorexia nervosa. Biol Psychiatry 1994; 35:48-53.
11. Devlin MJ, Walsh BT, Kral JG, et al. Metabolic abnormalities in bulimia nervosa. Arch Gen Psychiatry 1990; 47:144-148.
12. Altemus M, Hetherington M, Flood M. Decrease in resting metabolic rate during abstinence from bulimic behavior. Am J Psychiatry 1991; 148:1071-1072.
13. Spalter AR, Gwirtsman HE, Demitrack MA, et al. Throid function in bulimia nervosa. Biol Psychiatry 1993; 33:408-414.
14. Wadden TA, Foster GD, Letizia KA, Wilk JE. Metabolic, anthropometric, and psychological characteristics of obese binge eaters. Int J Eat Disord 1993; 14:127-135.
15. Morley JE, Bhmdell JE. The neurobiological basis of eating disorders: some formulations. Biol Psychiatry 1988; 23:53-78.
16. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000; 404:661-671.
17. Jimerson DC, Wolfe BE, Naab S. In: Anorexia nervosa and bulimia nervosa. CE, Brumback RA, eds. Textbook of Pediatric Neuropsychiatry Coffee Washington, DC: American Psychiatric Press, 1998:563-578.
18. Stoving RK, Hangaard J, Hansen-Nord M, Hagen C. A review of endocrine changes in anorexia nervosa. J Psychiatr Res 1999; 33:139-152.
19. Kaye WH, Gwirtsman HE, George DT, Ebert MH, Jimerson DC, Tomai TP, Chrousos GP, Gold PW. Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression. J Clin Endocrinol Metab 1987; 64:203-208.
20. Walsh BT, Roose SP, Katz JL, Dyrenfurth I, Wright L, Vande Wiele R, Glassman AH. Hypothalamic-pituitary-adrenal-cortical activity in anorexia nervosa and bulimia. Psychoneuroendocrinology 1987; 12:131-140.
21. Licinio J, Wong ML, Gold PW. The hypothalamic-pituitary-adrenal axis in anorexia nervosa. Psychiatry Res 1996; 62:75-83.
22. Glowa JR, Gold PW. Corticotropin releasing hormone produces profound anorexigenic effects in the rhesus monkey. Neuropeptides 1991; 18:55-61.
23. Rivier C, Vale W. Influence of corticotropin releasing factor on reproductive functions in the rat. Endocrinology 1984; 114:914-921.
24. Sirinathsinghji DJ, Rees LH, Rivier J. Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat. Nature 1983; 305:232-235.
25. Sutton RE, Koob GF, LeMoal M. Corticotropin-releasing factor produces behavioral activation in rats. Nature 1982; 297:331-333.
26. Morley JE, Levine AS, Gosnell BA, Mitchell JE, Krahn DD, Nizielski SE. Peptides and feeding. Peptides 1985; 6:181-192.
27. Kaye WH, Berrettini WH, Gwirtsman HE, Chretien M, Gold PW, George DT, Jimerson DC, Ebert MH. Reduced cerebrospinal fluid levels of immunoreactive pro-opiomelanocortin related peptides (including beta-endorphin) in anorexia nervosa. Biol Psychiatry 1987; 41:2147-2155.
28. Lesem MD, Berrettini W, Kaye WH, Jimerson DC. Measurement of CSF dynorphin A 1-8 immunoreactivity in anorexia nervosa and normal-weight bulimia. Biol Psychiatry 1991; 29:244-252.
29. Brewerton TD, Lydiard RB, Laraia MT, Shook JE, Ballenger JC. CSF betaendorphin and dynorphin in bulimia nervosa. Am J Psychiatry 1992; 149:1086-1090.
30. Brambilla F, Brunetta M, Peirone A, Perna G, Sacerdote P, Manfredi B, Panerai AE. T-lymphocyte cholecystokinin-8 and beta-endorphin concentrations in eating disorders: I. Anorexia nervosa. Psychiatry Res 1995; 59:43-50.
31. Brambilla F, Brunetta M, Draisci A, Manfredi B, Panerai AE, Peirone A, Perna G, Sacerdote P. T-lymphocyte cholecystokinin-8 and beta-endorphin in eating disorders: II. Bulimia nervosa. Psychiatry Res 1995; 59:51-56.
32. Grossman A. Brain opiates and neuroendocrine function. Clin Endocrinol Metab 1983; 12:725-746.
33. Pfeiffer A, Herz A. Endocrine actions of opioids. Horm Metab Res 1984; 16:386-397.
34. Armeanu M, Berkhout GMJ, Schoemaker J. Pulsatile luteinizing hormone secretion in hypothalamic amenorrhea, anorexia nervosa, and polycystic ovarian disease during naltrexone treatment. Fertil Steril 1992; 57:762-770.
35. Bohus B, Kovacs GL, De Weid D. Oxytocin, vasopressin and memory: opposite effects on consolidation and retrial process. Brain Res 1978; 157:414-417.
36. Nishita JK, Ellinwood EH Jr, Rockwell WJ. Abnormalities in the response of plasma arginine vasopressin durinh hypertonic saline infusion in patients with eating disorders. Biol Psychiatry 1989; 26:73-86.
37. Demitrack MA, Lesem MD, Listwak SJ. CSF oxytocin in anorexia nervosa and bilimia nervosa: clinical and pathophysiological considerations. Am J Psychiatry 1990; 147:882-886.
38. Chiodera P, Volpi R, Capretti L. Effect of estrogen or insulin-induced hypoglycemia on plasma oxytocin levels in bulimia and anorexia nervosa. Metabolism 1991; 40:1226-1230.
39. Gold PW, Kaye WH, Robertson GL, et al. Abnormalities in plasma and cerebrospinal-fluid arginine vasopressin in patients with anorexia nervosa. N Engl J Med 1983; 308:1117-1123.
40. Kalra SP, Dube MG, Sahu A, Phelps CP, Kalra PS. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci USA 1991; 88:10931-10935.
41. Kaye WH, Berrettini W, Gwirtsman H, George DT. Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa. Arch Gen Psychiatry 1990; 47:548-556.
42. Gendall K. Leptin, neuropeptide Y, and peptide YY in long-term recovered eating disorder patients. Biol Psychiatry 1999; 46:292-299.
43. Baranowska B, Wolinska-Witort E, Wasilewska-Dziubinska E, Roguski K, Chmielowska M. Plasma leptin, neuropeptide Y (NPY) and galanin concentrations in bulimia nervosa and in anorexia nervosa. Neuroendocrinol Lett 2001; 22:356-358.
44. Gibbs J, Young RC, Smith GP. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychology 1973; 84:488-495.
45. Geracioti TD Jr, Liddle RA. Impaired cholecystokinin secretion in bulimia nervosa. N Engl J Med 1988; 319:683-688.
46. Phillipp E, Pirke KM, Kellner MB, Krieg JC. Disturbed cholecystokinin secretion in patients with eating disorders. Life Sci 1991; 48:2443-2450.
47. Pirke KM, Kellner MB, Friess E, Krieg JC, Fichter MM. Satiety and cholecystokinin. Int J Eat Disord 1994; 15:63-69.
48. Devlin MJ, Walsh BT, Guss JL, Kissileff HR, Liddle RA, Petkova E. Post prandial cholecystokinin release and gastric emptying in patients with bulimia nervosa. Am J Clin Nutr 1997; 65:114-120.
49. Lydiard RB, Brewerton TD, Fossey MD, Laraia MT, Stuart G, Beinfeld MC, Ballenger JC. CSF cholecystokinin octapeptide in patients with bulimia nervosa and in normal comparison subjects. Am J Psychiatry 1993; 150:1099-1101.
50. Tamai H, Takemura J, Kobayashi N, Matsubayashi S, Matsukura S, Nakagawa T. Changes in plasma cholecystokinin concentrations after oral glucose tolerance test in anorexia nervosa before and after therapy. Metab Clin Exp 1993; 42:581-584.
51. Harty RF, Pearson PH, Solomon TE, McGuigan JE. Cholecystokinin, vasoactive intestinal peptide and peptide histidine methionine responses to feeding in anorexia nervosa. Regul Peptides 1991; 36:141-150.
52. Geracioti TD Jr, Liddle RA, Altemus M, Demitrack MA, Gold PW. Regulation of appetite and cholecystokinin secretion in anorexia nervosa. Am J Psychiatry 1992; 149:958-961.
53. Baranowska B, Radzikowska M, Wasilewska-Dziubinska E, Roguski K, Borowiec M. Disturbed release of gastrointestinal peptides in anorexia nervosa and in obesity. Diabetes Obes Metab 2000; 2:99-103.
54. Geliebter A, Melton PM, McCray RS, Gallagher DR, Gage D, Hashim SA. Gastric capacity, gastric emptying, and test-meal intake in normal and bulimic women. Am J Clin Nutr 1992; 56:656-661.
55. Considine RV, Considine EL, Williams CJ, Hyde TM, Caro JF. The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations. Diabetes 1996; 45:992-994.
56. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D Jr. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nature Med 1996; 2:589-593.
57. Farooqi IS, Keogh JM, Kamath S, Jones S, Gibson WT, Trussell R, Jebb SA, Lip GY, O’Rahilly S. Partial leptin deficiency and human adiposity. Nature 2001; 414:34-35.
58. Hebebrand J, van der Heyden J, Devos R, Kopp W, Herpertz S, Remschmidt H, Herzog W. Plasma concentrations of obese protein in anorexia nervosa. Lancet 1995; 346:1624-1625.
59. Grinspoon S, Gulick T, Askari H, Landt M, Lee K, Anderson E, Ma Z, Vignati L, Bowsher R, Herzog D, Klibanski A. Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab 1996; 81:3861-3863.
60. Mantzoros C, Flier JS, Lesem MD, Brewerton TD, Jimerson DC. Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain. J Clin Endocrinol Metab 1997; 82:1845-1851.
61. Eckert ED, Pomeroy C, Raymond N, Kohler PF, Thuras P, Bowers CY. Leptin in anorexia nervosa. J Clin Endocrinol Metab 1998; 83:791-795.
62. Frederich R, Hu S, Raymond N, Pomeroy C. Leptin in anorexia nervosa and bulimia nervosa: importance of assay technique and method of interpretation. J Lab Clin Med 2002; 139:72-79.
63. Jimerson DC. Leptin and the neurobiology of eating disorders. J Lab Clin Med 2002; 139:70-71.
64. Brewerton TD, Lesem MD, Kennedy A, Garvey WT. Reduced plasma leptin concentration in bulimia nervosa. Psychoneuroendocrinology 2000; 25:649-658.
65. Jimerson DC, Mantzoros C, Wolfe BE, Metzger ED. Decreased serum leptin in bulimia nervosa. J Clin Endocrinol Metab 2000; 85:4511-4514.
66. Monteleone P, Bortolotti F, Fabrazzo M, La Rocca A, Fuschino A, Maj M. Plasma leptin response to acute fasting and refeeding in untreated women with bulimia nervosa. J Clin Endocrinol Metab 2000; 85:2499-2503.
67. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. A role for ghrelin in the central regultion of feeding. Nature 2001; 409:194-198.
68. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, Nozoe S, Hosoda H, Kangawa K, Matsukura S. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Endocrinol Metab 2002; 87:240-244.
69. Tanaka M, Naruo T, Muranaga T, Yasuhara D, Shiiya T, Nakazato M, Matsukura S, Nozoe S. Increased fasting plasma ghrelin levels in patients with bulimia nervosa. Eur J Endocrinol 2002; 146:R1-R3.
70. Tschop M, Weyer C, Tataranni AP, Devanarayan V, Ravussin B, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001; 50:707-709.
71. Otto B, Cuntz U, Fruehauf E, Wawarta R, Folwaczny C, Riepl RL, Heiman ML, Lehnert P, Fichter M, Tschöp M. Weight gain decrease elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 2001; 145:669-673.
72. Brown M, Marki W, Rivier J. Is gastrin releasing peptide mammalian bombesin? LifeSci 1980; 27:125-128.
73. Bray GA. Nutrient intake is modulated by peripheral petide aministration. Obesity Res 1995; 3(Suppl. 4):569S-572S.
74. Flynn FW. Bombesin-like peptides in the reglation of ingestive behavior. Ann NY Acad Sci 1994; 739:120-134.
75. Ladenheim EE, Jensen RT, Mantey SA, Moran TH. Distinct distributions of two bombesin receptor subtypes in the rat central nervous system. Brain Res 1992; 593:168-178.
76. Wolf SS, Moody TW. Receptors for GRP/bombesin-like peptides in the rat forebrain. Peptides 1985; 6(Suppl. 1):111-114.
77. Ladenheim EE, Wirth KE, Moran TH. Receptor subtype mediation of feeding suppression by bombesin-like peptides. Pharmacol Biochem Behav 1996; 54:705-711.
78. Frank GK, Kaye WH, Ladenheim EE, McConaha C. Reduced gastrin releasing peptide in cerebrospinal fluid after recovery from bulimia nervosa. Appetite 2001; 37:9-14.